Search the Community
Showing results for tags 'mdma'.
Found 4 results
The award-winning documentary, ‘From Shock to Awe’ shines light on the use of cutting-edge psychedelic medicines to treat mental illness in war veterans. The Australian Psychedelic Society (APS) is premiering the documentary across Australia with a panel of guest speakers, thanks to sponsorship from Vasudhara, Psychedelic Research in Science & Medicine (PRISM) and Aadii Mesh Foundation. BACKGROUND In 2018, an alarming report published by the Department of Veterans Affairs shows the impact of service on the mental health of veterans, with 46 percent of veterans who left the Australian Defence Force (ADF) experiencing a mental disorder within 5 years. The most common problem is anxiety, with one in three veterans saying they experienced symptoms. The other common illnesses were post-traumatic stress disorder (PTSD; 18 percent), panic attacks (17 percent) and depression (12 percent). Suicide also represents a major issue, with one in five veterans experiencing suicidal thoughts, plans or attempts. For males under 30, the completed suicide rates of veterans who left service are 17 percent above the national average (graph taken from the ABC). PSYCHEDELIC MEDICINES - A NEW FRONTIER IN MENTAL HEALTH After more than 50 years of dormancy, a new psychedelic revolution is taking place. Initial studies show that psychedelic drugs, including ayahuasca (traditional amazonian brew), psilocybin (magic mushrooms) and MDMA have profound effects in alleviating mental illness. They also work in a vastly different manner to traditional psychiatric medications. Neuroscientist, Dr Dean Wright states that “Traditional psychiatric medications, such as antidepressants require daily use, have many side-effects, and are not much more efficacious than placebo. In contrast, psychedelic therapies require between one and three doses in total, with effects lasting up to four years after the final dose.” St Vincent’s Hospital, Melbourne and Psychedelic Research in Science & Medicine (PRISM) have launched an Australian first clinical trial using psilocybin to treat anxiety and depression associated with a terminal illness. In the USA, MDMA-therapy for PTSD has been designated a “breakthrough treatment” by the FDA. It appears imminent that these therapies will be approved as medicines. FROM SHOCK TO AWE The film follows veterans, Matt Kahl and Mike Cooley, through their challenging post-war lives, shattered by the trauma of war. It also explores the impact on their wives, Aimee and Brooke. The vets struggle with anxiety, fear, depression, anger, unable to find equilibrium with society and with their families. After confronting death multiple times, our heroes set out on a journey to treat their mental illness with Ayahuasca and MDMA. “I tried everything...all the medications, EMDR, exposure therapy, talk therapy, group therapy and the truth is, none of it worked. It was ruining my family,” says Veteran Matt Kahl. Brooke Cooley goes further stating, “Ayahuasca and MDMA saved me, my husband and my family. Had psychedelic therapy not come into our lives, not only would Mike and I be divorced, but there is a solid chance that one or both of us wouldn’t be alive.” FILM SCREENING & PANEL DISCUSSION The Australian Psychedelic Society will host the Australian premier screening of ‘From Shock to Awe’ across 5 cities. Following the film there will be a Q&A with Mitch Schultz, the film’s Transmedia Producer and Major Steve McDonald, an Australian war veteran who utilised psychedelic medicines to successfully treat his depression and PTSD. EVENT DETAILS BYRON BAY: Sunday August 18th, 2.30pm The Byron Theatre Facebook event Tickets = $30/$25 concession BRISBANE: Saturday 24th August, 1.30pm Kindler Theatre, QUT, Brisbane Facebook event. Tickets = $20-$25 ADELAIDE: Saturday 31st August, 2.30pm Mercury Theatre, 13 Morphett St, Adelaide Facebook event Tickets = $20-$25 SYDNEY: Saturday 7th September, 12.30pm Giant Dwarf, 199 Cleveland St, Redfern Facebook event Tickets = $20-$30 MELBOURNE Saturday 14th September, 12.30pm The State Library Theatrette, Melbourne Facebook event Tickets = $20-$25
Slocombe posted a topic in Legal MattersThought this was worth sharing/discussing. Headline from the Canberra Times http://www.canberratimes.com.au/act-news/drug-importation-trial-collapses-legal-flaws-mean-designer-drug-is-not-border-controlled-20150717-gielrw.html ~~~~~~~~~~~~~~~~~~ Drug importation trial collapses, legal flaws mean designer drug is not 'border controlled By CHRISTOPHER KNAUS A significant drug importation case against a Canberra man has collapsed, exposing flaws with Commonwealth law that prevented a designer drug from being treated as "border controlled". The jury were directed to acquit Peter Edward Poulakis, 26, on Friday, a course that an ACT Supreme Court judge acknowledged may seem "a little unusual and perhaps even disturbing". "But the law is the law, and we apply the law very strictly in relation to criminal matters," Chief Justice Helen Murrell said. Mr Poulakis was on trial for aiding and abetting the importation of six large packages of drugs into Australia from the USA and China between June and August last year. He was allegedly having marketable quantities of drugs sent to hotels along Northbourne Avenue, using the fake identity of "Jason Causer" to pick them up. But an unexpected move by his defence led by barristers John Nicholson, SC, Duncan Berents, and solicitor Michael Kukulies-Smith saw the Crown's case unravel this week. The Crown had charged Mr Poulakis with helping to import an analogue, or a slightly tweaked version, of a drug listed as "border controlled". That analogue was MDEC, a variation on the border controlled drug butylone, which has similar effects to MDMA. The case came undone, however, because federal law bizarrely states that a substance cannot be treated as an analogue if it is itself named in either the Commonwealth's list of "controlled drugs" or "border controlled drugs". MDEC is named in Australia's list of "controlled drugs", and so Mr Nicholson argued the law meant it could not be defined as an analogue of the "border controlled drug" butylone. That led to the strange conclusion that MDEC could not possibly be a border controlled drug, meaning there was no way Mr Poulakis could be found guilty of the offences. The Crown had tried to argue that the law was ambiguous and the court should infer that such a situation cannot have been the intention of the parliament. But Chief Justice Murrell said the law was clear, and told the jury they must acquit Mr Poulakis on two counts. Earlier this week, the jury were also told to acquit Mr Poulakis on a further four counts, two of importing cocaine, and another two of importing MDEC in June last year. That occurred after Mr Nicholson convinced the court that there was no evidence that Mr Poulakis had known the four drug packages he was picking up in June contained imported drugs, as opposed to ones sent from within Australia. The Crown had spent more than a week leading its case against Mr Poulakis in the ACT Supreme Court. The prosecutor told Chief Justice Murrell her office would be "very interested" to read the reasons for ruling that MDEC could not be treated as an analogue of a border controlled drug. Mr Poulakis was allowed to walk free. He had faced a maximum of 25 years behind bars. Each package of MDEC contained more than 200 grams, while the two packages of cocaine each weighed close to 100 grams. Chief Justice Murrell thanked the jury, noting the case had been interesting, and encouraged them to read her decision when it was published.
Francois le Danque posted a topic in News & Noticeshttp://www.theage.co...1203-2ar04.html i really can't copy and paste the article, the formatting keeps going wrong...
at0m posted a topic in Chill Spacehttp://www.factmag.com/2012/09/19/keith-allen-and-lionel-shriver-to-take-mdma-in-live-televised-drug-trial-on-channel-4/